These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

249 related items for PubMed ID: 2560794

  • 1. Interleukin 2 induced non MHC-restricted killing of herpes simplex type-1 (HSV-1) infected allogeneic and autologous lymphoblasts.
    Klimpel GR, Asuncion M, Fons M, Norton JD, Albrecht T, Klimpel KD, Stein MD.
    J Clin Lab Immunol; 1989 May; 29(1):1-7. PubMed ID: 2560794
    [Abstract] [Full Text] [Related]

  • 2. Positively selected Leu-11a (CD16+) cells require the presence of accessory cells or factors for the lysis of herpes simplex virus-infected fibroblasts but not herpes simplex virus-infected Raji.
    Fitzgerald-Bocarsly P, Feldman M, Curl S, Schnell J, Denny T.
    J Immunol; 1989 Aug 15; 143(4):1318-26. PubMed ID: 2526183
    [Abstract] [Full Text] [Related]

  • 3. Functional heterogeneity among herpes simplex virus-specific human CD4+ T cells.
    Yasukawa M, Inatsuki A, Horiuchi T, Kobayashi Y.
    J Immunol; 1991 Feb 15; 146(4):1341-7. PubMed ID: 1671404
    [Abstract] [Full Text] [Related]

  • 4. Enhanced lysis of herpes simplex virus type 1-infected mouse cell lines by NC and NK effectors.
    Colmenares C, Lopez C.
    J Immunol; 1986 May 01; 136(9):3473-80. PubMed ID: 2420891
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Defective NK cell activity following thermal injury.
    Klimpel GR, Herndon DN, Fons M, Albrecht T, Asuncion MT, Chin R, Stein MD.
    Clin Exp Immunol; 1986 Nov 01; 66(2):384-92. PubMed ID: 3493101
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation.
    Lowdell MW, Shamim F, Hamon M, Macdonald ID, Prentice HG.
    Exp Hematol; 1995 Dec 01; 23(14):1530-4. PubMed ID: 8542943
    [Abstract] [Full Text] [Related]

  • 9. Interferon effect on cytotoxicity of peripheral blood and tumor-associated lymphocytes against human ovarian carcinoma cells.
    Allavena P, Introna M, Sessa C, Mangioni C, Mantovani A.
    J Natl Cancer Inst; 1982 Apr 01; 68(4):555-62. PubMed ID: 6175786
    [Abstract] [Full Text] [Related]

  • 10. Effects of herpes simplex virus on induced cell-mediated cytotoxicity in neonates and adults.
    Chin TW, Plaeger-Marshall S, Ank BJ, Pressman SR, Stiehm ER.
    Nat Immun Cell Growth Regul; 1991 Apr 01; 10(5):237-46. PubMed ID: 1661847
    [Abstract] [Full Text] [Related]

  • 11. Human natural killer cell recognition of herpes simplex virus type 1 glycoproteins: specificity analysis with the use of monoclonal antibodies and antigenic variants.
    Bishop GA, Marlin SD, Schwartz SA, Glorioso JC.
    J Immunol; 1984 Oct 01; 133(4):2206-14. PubMed ID: 6206157
    [Abstract] [Full Text] [Related]

  • 12. Lysis of herpes simplex virus (HSV) infected targets. IV. HSV-induced change in the effector population.
    Hendricks RL, Sugar J.
    Invest Ophthalmol Vis Sci; 1985 Feb 01; 26(2):208-13. PubMed ID: 3972502
    [Abstract] [Full Text] [Related]

  • 13. Role of interferon in human natural killer activity against target cells infected with HSV-1.
    Bishop GA, Glorioso JC, Schwartz SA.
    J Immunol; 1983 Oct 01; 131(4):1849-53. PubMed ID: 6194217
    [Abstract] [Full Text] [Related]

  • 14. Identification and selection of human lymphokine activated killer cell effectors and novel recycling intermediates by unique light-scattering properties.
    Loudon WG, Abraham SR, Owen-Schaub LB, Hemingway LL, Hemstreet GP, DeBault LE.
    Cancer Res; 1988 Apr 15; 48(8):2184-92. PubMed ID: 3258186
    [Abstract] [Full Text] [Related]

  • 15. Cytotoxicity against autologous, allogeneic, and xenogeneic tumor targets by human recombinant interleukin-2-activated lymphocytes from healthy dogs and dogs with lung tumors.
    Mitchell DH, Withrow SJ, Johnston MR, Kruse CA.
    Am J Vet Res; 1991 Jul 15; 52(7):1132-6. PubMed ID: 1892269
    [Abstract] [Full Text] [Related]

  • 16. Enhancement of susceptibility of HSV-1-infected cells to natural killer lysis by interferon.
    Muñoz A, Carrasco L, Fresno M.
    J Immunol; 1983 Aug 15; 131(2):783-7. PubMed ID: 6190939
    [Abstract] [Full Text] [Related]

  • 17. Human natural killer cells limit replication of herpes simplex virus type 1 in vitro.
    Fitzgerald PA, Mendelsohn M, Lopez C.
    J Immunol; 1985 Apr 15; 134(4):2666-72. PubMed ID: 2982949
    [Abstract] [Full Text] [Related]

  • 18. Lysis of herpes simplex virus (HSV) infected targets. III. Effect of HSV on natural killer activity.
    Hendricks RL, Sugar J.
    Invest Ophthalmol Vis Sci; 1985 Feb 15; 26(2):201-7. PubMed ID: 2579040
    [Abstract] [Full Text] [Related]

  • 19. Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. I. Lysis restricted by HLA class II MB and DR antigens.
    Yasukawa M, Zarling JM.
    J Immunol; 1984 Jul 15; 133(1):422-7. PubMed ID: 6609990
    [Abstract] [Full Text] [Related]

  • 20. Natural killer cellular cytotoxicity against herpes simplex virus-infected cells in Igh-1-disparate mice.
    Tamesis RR, Foster CS.
    Invest Ophthalmol Vis Sci; 1990 Nov 15; 31(11):2224-9. PubMed ID: 1700771
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.